Our research department is a leader in conducting state-of-the-art trials for neurological disorders.

Since 2002, we have participated in the approval process of safe and effective treatments for those diagnosed with epilepsy, migraines, and other neurological disorders.

We look forward to discussing our current studies with you to determine if you or your child meet eligibility criteria.

ACTIVELY ENROLLING STUDIES

Clinical studies are conducted at hospitals, universities and doctors' offices, and are the fastest and safest way to prove which treatments work best in patients.
Clinical studies are conducted at hospitals, universities and doctors’ offices, and are the fastest and safest way to prove which treatments work best in patients.

New-Onset or Recent-Onset Epilepsy– POS (with or without 2nd gen) or PGTCS
Ages: 2 – 15 years old

Generalized/Secondary Generalized/Mixed Seizures
Ages: 1 month – <18 years old

Primary Generalized Tonic-Clonic
Ages: 5 – 65 years old

Partial Onset Seizure
Ages: 1 month – 17 years old

Upper or Lower Limb Spasticity
Ages: 2 – <17 years old
Stable monoplegic, hemiplegic, or triplegic

Dravet Syndrome
Ages: 2 – 18 years old

Glut 1 Deficiency
Ages: 1- <35 years old

Tourette Syndrome
Ages: Children and adolescents, 6-16 years old

Any Epilepsy Type
Ages: 1 month to less than 24 months old

For more information, please contact:
Denise Hubert
Phone: 407.293.1122, ext. 226
Fax: 407.253.2170